[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fudayG4T70zqDc9P7BkJtXsF1EedvXvKG60xwpMofWN8":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":35,"phaseBuckets":46,"rows":53},"National University of Singapore",[4],199,false,54,6,125290,15,195,[14,17,20,23,25,28,30,32],{"name":15,"count":16},"Anxiety",12,{"name":18,"count":19},"Sleep",11,{"name":21,"count":22},"Stress",10,{"name":24,"count":22},"Aging",{"name":26,"count":27},"Breast Cancer",7,{"name":29,"count":27},"Obstructive Sleep Apnea",{"name":31,"count":9},"Depression",{"name":33,"count":34},"Stroke",5,[36,41],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT07004049","Optimising TREATment for Severe Gram-Negative Bacterial Infections","2028-12-31","Colistin\u002FPolymyxin B + Sulbactam",{"nctId":42,"briefTitle":43,"date":44,"intervention":45},"NCT07282041","Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis","2030-12-01","Dulaglutide",[47,48,49,50,51,52],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[54,95,113,131,149,167,185,203,221,239,257,275,293,311,329,351,377],{"intervention":40,"totalTrials":55,"cells":56},1,{"EARLY_PHASE1":57,"PHASE1":60,"PHASE2":62,"PHASE3":64,"PHASE4":66,"NA":93},{"trials":58,"activeCount":59},[],0,{"trials":61,"activeCount":59},[],{"trials":63,"activeCount":59},[],{"trials":65,"activeCount":59},[],{"trials":67,"activeCount":55,"soonestReadout":39},[68],{"nctId":37,"briefTitle":38,"status":69,"phases":70,"primaryCompletion":39,"completion":39,"start":71,"enrollment":72,"conditions":73,"interventions":79},"RECRUITING",[51],"2025-04-21",600,[74,75,76,77,78],"Bloodstream Infection","Ventilator Associated Bacterial Pneumonia","Hospital Acquired Bacterial Pneumonia","Carbapenem Resistant Bacterial Infection","Multidrug Resistance",[40,80,81,82,83,84,85,86,87,88,89,90,91,92],"Colistin\u002FPolymyxin B + Tigecycline\u002FEravacycline","Colistin\u002FPolymyxin B + Meropenem","Ceftazidime-avibactam + Sulbactam","Ceftazidime-avibactam + Fosfomycin","Ceftazidime-avibactam","Ceftazidime-avibactam + Aztreonam","Ceftazidime-avibactam + Colistin\u002FPolymyxin B","High-dose meropenem","Meropenem + Fosfomycin","Meropenem-vaborbactam","Cefiderocol","Ceftolozane-tazobactam","Ceftolozane-tazobactam + Meropenem",{"trials":94,"activeCount":59},[],{"intervention":80,"totalTrials":55,"cells":96},{"EARLY_PHASE1":97,"PHASE1":99,"PHASE2":101,"PHASE3":103,"PHASE4":105,"NA":111},{"trials":98,"activeCount":59},[],{"trials":100,"activeCount":59},[],{"trials":102,"activeCount":59},[],{"trials":104,"activeCount":59},[],{"trials":106,"activeCount":55,"soonestReadout":39},[107],{"nctId":37,"briefTitle":38,"status":69,"phases":108,"primaryCompletion":39,"completion":39,"start":71,"enrollment":72,"conditions":109,"interventions":110},[51],[74,75,76,77,78],[40,80,81,82,83,84,85,86,87,88,89,90,91,92],{"trials":112,"activeCount":59},[],{"intervention":81,"totalTrials":55,"cells":114},{"EARLY_PHASE1":115,"PHASE1":117,"PHASE2":119,"PHASE3":121,"PHASE4":123,"NA":129},{"trials":116,"activeCount":59},[],{"trials":118,"activeCount":59},[],{"trials":120,"activeCount":59},[],{"trials":122,"activeCount":59},[],{"trials":124,"activeCount":55,"soonestReadout":39},[125],{"nctId":37,"briefTitle":38,"status":69,"phases":126,"primaryCompletion":39,"completion":39,"start":71,"enrollment":72,"conditions":127,"interventions":128},[51],[74,75,76,77,78],[40,80,81,82,83,84,85,86,87,88,89,90,91,92],{"trials":130,"activeCount":59},[],{"intervention":82,"totalTrials":55,"cells":132},{"EARLY_PHASE1":133,"PHASE1":135,"PHASE2":137,"PHASE3":139,"PHASE4":141,"NA":147},{"trials":134,"activeCount":59},[],{"trials":136,"activeCount":59},[],{"trials":138,"activeCount":59},[],{"trials":140,"activeCount":59},[],{"trials":142,"activeCount":55,"soonestReadout":39},[143],{"nctId":37,"briefTitle":38,"status":69,"phases":144,"primaryCompletion":39,"completion":39,"start":71,"enrollment":72,"conditions":145,"interventions":146},[51],[74,75,76,77,78],[40,80,81,82,83,84,85,86,87,88,89,90,91,92],{"trials":148,"activeCount":59},[],{"intervention":83,"totalTrials":55,"cells":150},{"EARLY_PHASE1":151,"PHASE1":153,"PHASE2":155,"PHASE3":157,"PHASE4":159,"NA":165},{"trials":152,"activeCount":59},[],{"trials":154,"activeCount":59},[],{"trials":156,"activeCount":59},[],{"trials":158,"activeCount":59},[],{"trials":160,"activeCount":55,"soonestReadout":39},[161],{"nctId":37,"briefTitle":38,"status":69,"phases":162,"primaryCompletion":39,"completion":39,"start":71,"enrollment":72,"conditions":163,"interventions":164},[51],[74,75,76,77,78],[40,80,81,82,83,84,85,86,87,88,89,90,91,92],{"trials":166,"activeCount":59},[],{"intervention":84,"totalTrials":55,"cells":168},{"EARLY_PHASE1":169,"PHASE1":171,"PHASE2":173,"PHASE3":175,"PHASE4":177,"NA":183},{"trials":170,"activeCount":59},[],{"trials":172,"activeCount":59},[],{"trials":174,"activeCount":59},[],{"trials":176,"activeCount":59},[],{"trials":178,"activeCount":55,"soonestReadout":39},[179],{"nctId":37,"briefTitle":38,"status":69,"phases":180,"primaryCompletion":39,"completion":39,"start":71,"enrollment":72,"conditions":181,"interventions":182},[51],[74,75,76,77,78],[40,80,81,82,83,84,85,86,87,88,89,90,91,92],{"trials":184,"activeCount":59},[],{"intervention":85,"totalTrials":55,"cells":186},{"EARLY_PHASE1":187,"PHASE1":189,"PHASE2":191,"PHASE3":193,"PHASE4":195,"NA":201},{"trials":188,"activeCount":59},[],{"trials":190,"activeCount":59},[],{"trials":192,"activeCount":59},[],{"trials":194,"activeCount":59},[],{"trials":196,"activeCount":55,"soonestReadout":39},[197],{"nctId":37,"briefTitle":38,"status":69,"phases":198,"primaryCompletion":39,"completion":39,"start":71,"enrollment":72,"conditions":199,"interventions":200},[51],[74,75,76,77,78],[40,80,81,82,83,84,85,86,87,88,89,90,91,92],{"trials":202,"activeCount":59},[],{"intervention":86,"totalTrials":55,"cells":204},{"EARLY_PHASE1":205,"PHASE1":207,"PHASE2":209,"PHASE3":211,"PHASE4":213,"NA":219},{"trials":206,"activeCount":59},[],{"trials":208,"activeCount":59},[],{"trials":210,"activeCount":59},[],{"trials":212,"activeCount":59},[],{"trials":214,"activeCount":55,"soonestReadout":39},[215],{"nctId":37,"briefTitle":38,"status":69,"phases":216,"primaryCompletion":39,"completion":39,"start":71,"enrollment":72,"conditions":217,"interventions":218},[51],[74,75,76,77,78],[40,80,81,82,83,84,85,86,87,88,89,90,91,92],{"trials":220,"activeCount":59},[],{"intervention":87,"totalTrials":55,"cells":222},{"EARLY_PHASE1":223,"PHASE1":225,"PHASE2":227,"PHASE3":229,"PHASE4":231,"NA":237},{"trials":224,"activeCount":59},[],{"trials":226,"activeCount":59},[],{"trials":228,"activeCount":59},[],{"trials":230,"activeCount":59},[],{"trials":232,"activeCount":55,"soonestReadout":39},[233],{"nctId":37,"briefTitle":38,"status":69,"phases":234,"primaryCompletion":39,"completion":39,"start":71,"enrollment":72,"conditions":235,"interventions":236},[51],[74,75,76,77,78],[40,80,81,82,83,84,85,86,87,88,89,90,91,92],{"trials":238,"activeCount":59},[],{"intervention":88,"totalTrials":55,"cells":240},{"EARLY_PHASE1":241,"PHASE1":243,"PHASE2":245,"PHASE3":247,"PHASE4":249,"NA":255},{"trials":242,"activeCount":59},[],{"trials":244,"activeCount":59},[],{"trials":246,"activeCount":59},[],{"trials":248,"activeCount":59},[],{"trials":250,"activeCount":55,"soonestReadout":39},[251],{"nctId":37,"briefTitle":38,"status":69,"phases":252,"primaryCompletion":39,"completion":39,"start":71,"enrollment":72,"conditions":253,"interventions":254},[51],[74,75,76,77,78],[40,80,81,82,83,84,85,86,87,88,89,90,91,92],{"trials":256,"activeCount":59},[],{"intervention":89,"totalTrials":55,"cells":258},{"EARLY_PHASE1":259,"PHASE1":261,"PHASE2":263,"PHASE3":265,"PHASE4":267,"NA":273},{"trials":260,"activeCount":59},[],{"trials":262,"activeCount":59},[],{"trials":264,"activeCount":59},[],{"trials":266,"activeCount":59},[],{"trials":268,"activeCount":55,"soonestReadout":39},[269],{"nctId":37,"briefTitle":38,"status":69,"phases":270,"primaryCompletion":39,"completion":39,"start":71,"enrollment":72,"conditions":271,"interventions":272},[51],[74,75,76,77,78],[40,80,81,82,83,84,85,86,87,88,89,90,91,92],{"trials":274,"activeCount":59},[],{"intervention":90,"totalTrials":55,"cells":276},{"EARLY_PHASE1":277,"PHASE1":279,"PHASE2":281,"PHASE3":283,"PHASE4":285,"NA":291},{"trials":278,"activeCount":59},[],{"trials":280,"activeCount":59},[],{"trials":282,"activeCount":59},[],{"trials":284,"activeCount":59},[],{"trials":286,"activeCount":55,"soonestReadout":39},[287],{"nctId":37,"briefTitle":38,"status":69,"phases":288,"primaryCompletion":39,"completion":39,"start":71,"enrollment":72,"conditions":289,"interventions":290},[51],[74,75,76,77,78],[40,80,81,82,83,84,85,86,87,88,89,90,91,92],{"trials":292,"activeCount":59},[],{"intervention":91,"totalTrials":55,"cells":294},{"EARLY_PHASE1":295,"PHASE1":297,"PHASE2":299,"PHASE3":301,"PHASE4":303,"NA":309},{"trials":296,"activeCount":59},[],{"trials":298,"activeCount":59},[],{"trials":300,"activeCount":59},[],{"trials":302,"activeCount":59},[],{"trials":304,"activeCount":55,"soonestReadout":39},[305],{"nctId":37,"briefTitle":38,"status":69,"phases":306,"primaryCompletion":39,"completion":39,"start":71,"enrollment":72,"conditions":307,"interventions":308},[51],[74,75,76,77,78],[40,80,81,82,83,84,85,86,87,88,89,90,91,92],{"trials":310,"activeCount":59},[],{"intervention":92,"totalTrials":55,"cells":312},{"EARLY_PHASE1":313,"PHASE1":315,"PHASE2":317,"PHASE3":319,"PHASE4":321,"NA":327},{"trials":314,"activeCount":59},[],{"trials":316,"activeCount":59},[],{"trials":318,"activeCount":59},[],{"trials":320,"activeCount":59},[],{"trials":322,"activeCount":55,"soonestReadout":39},[323],{"nctId":37,"briefTitle":38,"status":69,"phases":324,"primaryCompletion":39,"completion":39,"start":71,"enrollment":72,"conditions":325,"interventions":326},[51],[74,75,76,77,78],[40,80,81,82,83,84,85,86,87,88,89,90,91,92],{"trials":328,"activeCount":59},[],{"intervention":45,"totalTrials":55,"cells":330},{"EARLY_PHASE1":331,"PHASE1":333,"PHASE2":335,"PHASE3":337,"PHASE4":347,"NA":349},{"trials":332,"activeCount":59},[],{"trials":334,"activeCount":59},[],{"trials":336,"activeCount":59},[],{"trials":338,"activeCount":55,"soonestReadout":44},[339],{"nctId":42,"briefTitle":43,"status":69,"phases":340,"primaryCompletion":44,"completion":44,"start":341,"enrollment":342,"conditions":343,"interventions":346},[49,50],"2025-12-17",130,[344,345],"Intracranial Atherosclerosis","Stroke, Ischemic",[45],{"trials":348,"activeCount":59},[],{"trials":350,"activeCount":59},[],{"intervention":352,"totalTrials":55,"cells":353},"Early intensive BP control",{"EARLY_PHASE1":354,"PHASE1":356,"PHASE2":358,"PHASE3":360,"PHASE4":373,"NA":375},{"trials":355,"activeCount":59},[],{"trials":357,"activeCount":59},[],{"trials":359,"activeCount":59},[],{"trials":361,"activeCount":59},[362],{"nctId":363,"briefTitle":364,"status":365,"phases":366,"primaryCompletion":367,"completion":367,"start":368,"enrollment":8,"conditions":369,"interventions":372},"NCT03443596","Blood Pressure Control in Acute Ischemic Stroke","COMPLETED",[49,50],"2019-03-13","2014-12-01",[370,371],"Blood Pressure","Acute Stroke",[352],{"trials":374,"activeCount":59},[],{"trials":376,"activeCount":59},[],{"intervention":378,"totalTrials":55,"cells":379},"Allocating head-of-bed position",{"EARLY_PHASE1":380,"PHASE1":382,"PHASE2":384,"PHASE3":386,"PHASE4":400,"NA":402},{"trials":381,"activeCount":59},[],{"trials":383,"activeCount":59},[],{"trials":385,"activeCount":59},[],{"trials":387,"activeCount":59},[388],{"nctId":389,"briefTitle":390,"status":391,"phases":392,"primaryCompletion":393,"completion":394,"start":395,"enrollment":396,"conditions":397,"interventions":399},"NCT05073159","Head-of-Bed Positioning in Large Artery Acute Ischemic Stroke","UNKNOWN",[50],"2024-03-30","2024-04-30","2020-02-11",182,[398],"Acute Ischemic Stroke",[378],{"trials":401,"activeCount":59},[],{"trials":403,"activeCount":59},[]]